Additionally, compared with DLBCL (14% nonmalignant B cells out of all B cells)42 and FL (7%–16%),67,68 MCL exhibits relatively low infiltration of nonmalignant B cells (3.8%), potentially limiting the efficacy of PD-1/PD-L1 therapies.69 The gene discussed is CD274; the disease is mantle cell lymphoma.